ANI Pharmaceuticals | ANIP - Les Charges D'Exploitation

Prix De L'Action
74.67
Variation Quotidienne
-0.15 -0.20%
Mensuellement
-0.57%
Annuel
16.20%
Q1 Prévisions
72.43




Les Charges D'Exploitation Changement Date
AbbVie USD 10.81B 13.45B 2025-12
ANI Pharmaceuticals USD 217.93M 287.88M 2025-12
Assertio Holdings USD 105.8M 12.5M 2025-09
Aurora Cannabis CAD 129.98M 16.05M 2025-12
Canopy Growth CAD 87.2M 6.22M 2025-12
Eli Lilly USD 10.31B 1.09B 2025-12
Emergent BioSolutions USD 555.9M 242.7M 2023-06
Heron Therapeutics USD 40.55M 1.46M 2025-12
Hikma Pharmaceutical USD 1.34B 702M 2025-12
Knight Therapeutics CAD 126.9M 8.29M 2025-12
Nektar Therapeutics USD 85.09M 109.3M 2025-09
Novartis USD 9.8B 23M 2025-12
Omeros USD 59.16M 20.13M 2024-06
Perrigo USD 1.03B 75.3M 2025-12
Sun Pharmaceuticals INR 111.11B 6.97B 2025-09
Teva Pharmaceutical Industries USD 4.22B 812M 2025-12